Immune response to pneumococcal conjugate and polysaccharide vaccines in otitis-prone and otitis-free children

Clinical Infectious Diseases

Volumn 29, Issue 1, 1999, Pages 191-192

  Barnett, Elizabeth D ^a,b   Pelton, Stephen I ^a,b   Cabral, Howard J ^a,b   Eavey, Roland D ^a,b   Allen, Carole ^a,b   Cunningham, Michael J ^a,b   McNamara, Eileen R ^a,b   Klein, Jerome O ^a,b  

^a BOSTON MEDICAL CENTER   (United States)

^b Children's Health Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA VACCINE; PNEUMOCOCCUS CONJUGATE VACCINE; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEVER; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; OTITIS MEDIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; SEROTYPE; STREPTOCOCCUS INFECTION;

EID: 0032772126     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520151     Document Type: Article

References (3)

1. 1. Black S, Shinefield H, Ray P, et al. Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37,000 infants and children: results of The Northern California Kaiser Permanente Efficacy Trial [abstract no LB-9]. In: Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 1998.
2. 2. Koskela M. Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination. Pediatr Infect Dis J 1987;6:519-26.
3. 3. Orange M, Gray BM. Pneumococcal serotypes causing disease in children in Alabama. Pediatr Infect Dis J 1993;12:244-6.